The 14th UK Stroke Forum Conference
The Clinical Outcomes team at Oxford University Innovation will be supporting Prof. Nele Demeyere and her team at the 14th UK Stroke Forum conference from the 3rd to the 5th December, Telford.
Global Access to Medicines networking evening 21st November 2019
OUI to attend Global Access to Medicines networking evening. The event seeks to catalyse the process of developing medicines that are available and affordable universally.
Assessing attitudes and anxiety toward mathematics – Mathematics Attitudes and Anxiety Questionnaire (MAAQ) now available!
The Clinical Outcomes team at Oxford University Innovation are very pleased to announce the launch of a standardised instrument used to detect math anxiety as early as possible and help monitor the condition at regular intervals.
ISPOR Europe 2019
Oxford University Innovation's Clinical Outcome team will be attending the annual ISPOR Europe 2019 conference in Copenhagen, Denmark from the 2nd - 6th November 2019.
ISOQOL 26th Annual Conference
Oxford University Innovation's Clinical Outcome team will be attending the annual 2019 ISOQOL conference in San Diego, CA from the 20th - 23rd October 2019.
ReQoL Community of Practice Event – 17th October, Sheffield UK
Sharing learning and knowledge about how ReQoL can be used to support person-centred, recovery-focused mental health services.
BioJapan 2019
Catch up with the latest developments from the Clinical Outcomes team at BioJapan 2019 in Pacifico Yokohama, from the 9th - 11th October.
The Clinical Outcomes team will be attending The International Congress of Parkinson’s Disease and Movement Disorders®
Dr David Churchman to represent the Clinical Outcomes team at the International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, from the 22nd - 26th September 2019.
ISPOR seeking input for discussions on developing “guiding principles” for COAs in real-world studies!
ISPOR Clinical Outcome Assessment Special Interest Group will be hosting a virtual roundtable meeting to examine ISPOR members’ opinions on developing guiding principles for the use of COAs in real world studies.
The Oxford Participation and Activities Questionnaire (OxPAQ) – Further validation for use in three more conditions
The generic Patient Reported Outcome (PRO) measure – the Oxford Participation and Activities Questionnaire (OxPAQ) has been further validated for use in three more common conditions.
© Oxford University Innovation